This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: La Trobe University, Transbio Ltd. Active years: 2015-2019.
Company Filing History:
Years Active: 2015-2019
Title: Amelia Jane Johnston: Innovator in Fn14 Binding Proteins
Introduction
Amelia Jane Johnston is a prominent inventor based in Melbourne, Australia. She has made significant contributions to the field of biotechnology, particularly in the development of proteins that target Fn14. With a total of 2 patents, her work focuses on innovative solutions for treating wasting disorders.
Latest Patents
Amelia's latest patents include the development of Fn14 binding proteins and their uses. The present disclosure provides proteins comprising antibody antigen binding domains that bind to Fn14 and outlines methods for treating wasting disorders, such as cachexia. This groundbreaking work has the potential to impact the treatment of various health conditions.
Career Highlights
Throughout her career, Amelia has worked with esteemed institutions such as La Trobe University and Transbio Ltd. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to significant advancements in biotechnology.
Collaborations
Amelia has collaborated with notable coworkers, including John Silke and Nicholas Johannes Hoogenraad. These partnerships have enriched her research and expanded the scope of her innovative projects.
Conclusion
Amelia Jane Johnston is a trailblazer in the field of biotechnology, with her work on Fn14 binding proteins paving the way for new treatments for wasting disorders. Her contributions to science and innovation continue to inspire future generations of inventors.